• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

JPM 2019

The Golden Gate Bridge
Biotech

Attendees fed up with venue, prices call to move JPM out of SF

While the high cost of living in San Francisco has famously grabbed headlines, the costs of simply meeting there are becoming untenable for some.
Conor Hale Jan 15, 2019 9:35am
Deciphera

Deciphera CBO Morl talks lines of therapy for kinase inhibitor ripretinib

Jan 11, 2019 11:10am
Illustration of three DNA helices

Orchard's 2019: Pipeline progress, new $90M manufacturing site

Jan 11, 2019 9:23am
San Francisco skyline

M&A, IPOs and VC raises: Biotech, medtech execs look to 2019

Jan 11, 2019 7:36am
Propeller Health

ResMed and Propeller Health announce new Walgreens partnership

Jan 10, 2019 3:42pm
San Francisco skyline

Aimmune’s peanut allergy drug outruns FDA shutdown; other programs not so lucky

Jan 10, 2019 11:36am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings